Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial...

by Dumbleton, J., Fitzmaurice, D., Fraser, S.D, Fuat, A., Gallagher, H., Griffith, K.E, Hawkey, C.J, Henderson, R.A, Lord, J., Lown, M., Maishman, T., Moore, M.V, Roderick, P.J, Stevens, P., Stevenson, D., Taal, M.W, Whitehead, A.
Published 2022

GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation

by Bassand, J.-P, Camm, A.J, Dalgaard, F., Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S., Haas, S., Kakkar, A.K, Kayani, G., Misselwitz, F., Oto, A., Piccini, J.P, Pieper, K.S, Turpie, A.G.G, Verheugt, F.W.A, Virdone, S.
Published 2022